```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Drug Infusion Systems market growth, commanding ~38% share in 2024. Accelerated adoption of smart pumps, CMS reimbursement for home-infusion, and a mature post-acute care ecosystem underpin the regional forecast. Hospital consolidation and venture-funded start-ups continue to channel capital into connected infusion platforms."
},
{
"type": "paragraph",
"content": "Europe (~27% share) benefits from MDR-driven upgrades, green procurement policies, and Horizon-Europe grants incentivising safer infusion technologies. Ageing demographics and cross-border e-prescription frameworks sustain replacement demand across Western and Eastern EU markets."
},
{
"type": "paragraph",
"content": "Asia Pacific is the fastest-growing region (CAGR >9%). Universal health insurance scaling in China and India, heavy capex into tertiary hospitals, and rising incidence of cancer and diabetes are primary drivers. Local manufacturing incentives and Japan’s regulatory fast-track for connected devices further amplify Drug Infusion Systems market growth."
},
{
"type": "paragraph",
"content": "Latin America (~8% share) is advancing through PAHO bulk-procurement alliances, mandatory quality accreditation for infusion pumps, and expanding private insurance. However, currency volatility tempers import-led regional forecast."
},
{
"type": "paragraph",
content: "Middle East & Africa (~7% share) is leveraging PPP hospital projects, Saudi Vision 2030 health privatisation, and Africa CDC initiatives to modernise infusion infrastructure, though under-reimbursement and low device penetration remain near-term constraints."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 38 },
{ "name": "Europe", "value": 27 },
{ "name": "Asia Pacific", "value": 20 },
{ "name": "Latin America", "value": 8 },
{ "name": "Middle East & Africa", "value": 7 }
]
}
}
```
